Literature DB >> 16206079

Babesia microti and Borrelia burgdorferi follow independent courses of infection in mice.

James L Coleman1, Dreania LeVine, Charles Thill, Christopher Kuhlow, Jorge L Benach.   

Abstract

Reports of coinfection with Borrelia burgdorferi and Babesia microti in tick vectors, reservoir hosts, and patients have led to increased concern that synergism between the 2 organisms may result in illness more severe than that caused by either infection alone. In the present study, we investigated the impact of simultaneous Lyme disease and babesiosis in the mouse model. Young immunocompetent, young asplenic, and aged C3H/HeN mice, as well as young BALB/c mice, were coinfected with B. burgdorferi and B. microti, and disease severity was compared with that in singly infected and uninfected control mice. Babesiosis followed its normal course of infection in coinfected mice, without evidence for increased severity, as reflected by percentage of parasitemia, spleen weights, and hematologic and clinical chemistry parameters. Likewise, Lyme disease followed its established course and severity in coinfected mice, as reflected by the degrees of spirochete dissemination and arthritis. This study demonstrates that, in the mouse model, these 2 infections proceed independently.

Entities:  

Mesh:

Year:  2005        PMID: 16206079     DOI: 10.1086/496891

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Parasite interactions in natural populations: insights from longitudinal data.

Authors:  S Telfer; R Birtles; M Bennett; X Lambin; S Paterson; M Begon
Journal:  Parasitology       Date:  2008-05-12       Impact factor: 3.234

Review 2.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 3.  Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease.

Authors:  Merrill Singer
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

4.  Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.

Authors:  Neeharik Mareedu; Anna M Schotthoefer; Jason Tompkins; Matthew C Hall; Thomas R Fritsche; Holly M Frost
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

Review 5.  Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease.

Authors:  Purnima Bhanot; Nikhat Parveen
Journal:  Int J Parasitol       Date:  2018-10-24       Impact factor: 3.981

6.  Robust adaptive immune response against Babesia microti infection marked by low parasitemia in a murine model of sickle cell disease.

Authors:  Woelsung Yi; Weili Bao; Marilis Rodriguez; Yunfeng Liu; Manpreet Singh; Vijendra Ramlall; Jeny R Cursino-Santos; Hui Zhong; Catherine M Elton; Gavin J Wright; Avital Mendelson; Xiuli An; Cheryl A Lobo; Karina Yazdanbakhsh
Journal:  Blood Adv       Date:  2018-12-11

Review 7.  Human Coinfection with Borrelia burgdorferi and Babesia microti in the United States.

Authors:  Kristen L Knapp; Nancy A Rice
Journal:  J Parasitol Res       Date:  2015-11-30

8.  Closely-related Borrelia burgdorferi (sensu stricto) strains exhibit similar fitness in single infections and asymmetric competition in multiple infections.

Authors:  Evelyn C Rynkiewicz; Julia Brown; Danielle M Tufts; Ching-I Huang; Helge Kampen; Stephen J Bent; Durland Fish; Maria A Diuk-Wasser
Journal:  Parasit Vectors       Date:  2017-02-06       Impact factor: 3.876

9.  Babesia microti Infection Changes Host Spleen Architecture and Is Cleared by a Th1 Immune Response.

Authors:  Vitomir Djokic; Lavoisier Akoolo; Nikhat Parveen
Journal:  Front Microbiol       Date:  2018-01-31       Impact factor: 5.640

10.  Co-infection of blacklegged ticks with Babesia microti and Borrelia burgdorferi is higher than expected and acquired from small mammal hosts.

Authors:  Michelle H Hersh; Richard S Ostfeld; Diana J McHenry; Michael Tibbetts; Jesse L Brunner; Mary E Killilea; Kathleen LoGiudice; Kenneth A Schmidt; Felicia Keesing
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.